MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...

A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

When you have too much potassium in your blood, it’s called hyperkalemia. There are two types of hyperkalemia: acute and chronic. Acute hyperkalemia is a sudden, severe rise in blood potassium levels.

Because you have hyperkalemia (a high potassium level), your doctor may want you to make changes to the foods you eat so potassium doesn’t build up in your blood. Often, that means cutting back on ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device Designation by the U.S. Food and Drug Administration ...

An oral potassium binder taken daily can enable the safe use of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure with reduced ejection fraction (HFrEF) who are at risk for ...

Please provide your email address to receive an email when new articles are posted on . Overall, 38 patients had hyperkalemia before dialysis, researchers found. A daily intake of greater than 15.33 g ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

Mild hyperkalemia is usually asymptomatic, whereas potassium levels of around 6.5 to 7 mmol/L can produce symptoms such as heart rhythm disturbances – including asystole, which is when the heart’s ...

A recent study published in the ArXiv preprint* server discusses the optimization of large language models (LLMs) for accurate differential diagnosis (DDx). Study: Towards Accurate Differential ...